The expression of P62 in RA-FLS and OA-FLS treated with 0.1ÎźM MTX for the indicated times (TIF 698 kb
Data of GFP-LC3B. The raw materials for statistics of percentage of punctate GFP cells in different ...
Figure S1. Characterization of TRAPs from tumor cell lines or cancer patients. Figure S2. Phenotype ...
Overview of the pathway analysis in the (a) tocilizumab plus methotrexate, (b) tocilizumab, and (c) ...
Detailed information of patients with RA enrolled in this study. Joint samples obtained from 10 diff...
Figure S1. Autophagy and apoptosis levels in PBMCs isolated from responding (A) and non-responding (...
Figure S1. Representative cytometric histograms of Cyto-ID staining in circulating CD4+ T cells (A1)...
Cell viability of MTX-treated fibroblasts. Cell viability of RA synovial fibroblasts measured by WST...
Description of the differentially co-expressed genes in the salmon module (tocilizumab plus methotre...
Immunochemisty and AP staining of iPSCs. a, b Immunocytochemistry of HC- and RA-iPSCs. HC: healthy c...
Patientsâ information. The table of patientsâ information used in this research. (PDF 16 kb
Plasmid constructs of Per2/Bik promoter. D-box(+), plasmid constructs containing D-box. D-box(−), pl...
Generation of iPSC-derived hepatocyte-like cells. a, b Morphology and immunocytochemistry images of ...
Figure S1. Normalized quantification of all immunoblots in the manuscript. A, The normalized quantif...
Correlations and corresponding P values between the modules and achieving sustained drug-free remiss...
Additional file 1: Note. Scottish Early Rheumatoid Arthritis inception cohort (SERA). Table S1. Prev...
Data of GFP-LC3B. The raw materials for statistics of percentage of punctate GFP cells in different ...
Figure S1. Characterization of TRAPs from tumor cell lines or cancer patients. Figure S2. Phenotype ...
Overview of the pathway analysis in the (a) tocilizumab plus methotrexate, (b) tocilizumab, and (c) ...
Detailed information of patients with RA enrolled in this study. Joint samples obtained from 10 diff...
Figure S1. Autophagy and apoptosis levels in PBMCs isolated from responding (A) and non-responding (...
Figure S1. Representative cytometric histograms of Cyto-ID staining in circulating CD4+ T cells (A1)...
Cell viability of MTX-treated fibroblasts. Cell viability of RA synovial fibroblasts measured by WST...
Description of the differentially co-expressed genes in the salmon module (tocilizumab plus methotre...
Immunochemisty and AP staining of iPSCs. a, b Immunocytochemistry of HC- and RA-iPSCs. HC: healthy c...
Patientsâ information. The table of patientsâ information used in this research. (PDF 16 kb
Plasmid constructs of Per2/Bik promoter. D-box(+), plasmid constructs containing D-box. D-box(−), pl...
Generation of iPSC-derived hepatocyte-like cells. a, b Morphology and immunocytochemistry images of ...
Figure S1. Normalized quantification of all immunoblots in the manuscript. A, The normalized quantif...
Correlations and corresponding P values between the modules and achieving sustained drug-free remiss...
Additional file 1: Note. Scottish Early Rheumatoid Arthritis inception cohort (SERA). Table S1. Prev...
Data of GFP-LC3B. The raw materials for statistics of percentage of punctate GFP cells in different ...
Figure S1. Characterization of TRAPs from tumor cell lines or cancer patients. Figure S2. Phenotype ...
Overview of the pathway analysis in the (a) tocilizumab plus methotrexate, (b) tocilizumab, and (c) ...
DOI
Add to ORKG